Breakup with Biogen on orelabrutinib for the treatment of autoimmune diseases
Considerations for the use of anthelminthic therapy for the treatment of neurocysticercosis
Technical consultation to assess evidence on community-based delivery of intermittent preventive treatment in pregnancy for malaria
The rising tide of climate finance - scope to adjust prudential treatment
The Hidden Toll of Drug Price Controls: Fewer New Treatments and Higher Medical Costs for the World
公众号
小程序
社群
公众号小程序社群